Abstract: The present disclosure relates to a nanoemulsion cosmetic composition including an oil phase and an aqueous phase, wherein the oil phase contains a ginseng nanopowder and an oil swollen by the ginseng nanopowder, the composition does not contain an additional surfactant, and the ginseng nanopowder is distributed uniformly in the composition. According to the present disclosure, there is provided a nanoemulsion cosmetic composition which contains a natural substance by containing a ginseng nanopowder and an oil swollen by the ginseng nanopowder in an oil phase and provides beneficial effect to skin.
Type:
Grant
Filed:
October 27, 2021
Date of Patent:
May 28, 2024
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Byoung Young Woo, Yong Deog Hong, Joonyoung Hwang
Abstract: Disclosed is a method for providing customized skin color matching sunscreen for a user. The method includes adding one or more basic sunscreen compounds, wherein the one or more sunscreen compounds includes at least one sun blocking active agent, adding a pigmented solution to the one or more basic sunscreen compounds, wherein the pigmented solution includes one or more pigments, determining a first amount of the one or more basic sunscreen compounds and a second amount of the pigmented solution for mixing, wherein the determining the first amount and the second amount is performed based on at least a skin tone of the user, and mechanically mixing the first amount and the second amount.
Abstract: An organic-mineral hybrid sunscreen composition is an oil-in-water emulsion of aqueous and oil phases. The oil phase includes at least one mineral UV filter comprising Zinc oxide, a blend of organic UV filters comprising ethylhexyl methoxycinnamate, ethylhexyl salicylate, octocrylene, and homosalate, at least one oil phase solvent, and at least one surfactant and the water phase includes water; at least one water-miscible solvent, and at least one polymer, and at least one filler. The organic-mineral hybrid sunscreen composition has an SPF of at least about 30 and a critical wavelength of at least 370 nm.
Type:
Grant
Filed:
July 29, 2022
Date of Patent:
May 14, 2024
Assignee:
L'OREAL
Inventors:
Jennifer Lynn Paulucci, Maximillian Baria, Jaimie Mecca, Patricia Brieva, Rose Maxwell
Abstract: A composition for application to a surface of skin includes from 0.1% to 1% by weight of at least one antimicrobial agent for disrupting a microbial cell, from 0.025% to 0.2% by weight of sodium gluconate as a micro-preservative potentiator also for disrupting a microbial cell, from 0.5% to 8% by weight of ethylhexyl isononanoate as an emollient for moisturizing a surface of skin, and from 0.005% to 0.04% by weight of a hyaluronic complex for hydrating the surface of skin. The hyaluronic complex includes a combination of hyaluronic acid, a salt derivative of hyaluronic acid, phenoxyethanol and water.
Type:
Grant
Filed:
February 17, 2022
Date of Patent:
May 7, 2024
Assignee:
Kao USA Inc.
Inventors:
Kevin Phifer, Lei Zhao, Mathieu Gervais, Wael Boutros
Abstract: This disclosure relates to a composition for facilitating transdermal delivery of vitamin D while preventing UV light from reaching user skin includes a concentration of cholecalciferol within a range of about 10 IU/g to about 40,000 IU/g. The composition includes one or more metal oxides such as zinc oxide and/or one or more titanium oxides which function to prevent (or at least limit) UV light from reaching user skin. The metal oxide(s) are provided at a concentration within a range of about 10% to about 50% by weight of the total composition.
Type:
Grant
Filed:
January 12, 2022
Date of Patent:
May 7, 2024
Assignee:
THE DAILY SUNCARE, LLC
Inventors:
Breelyn Jan Vanleeuwen, Ryan Clark Roberts
Abstract: A 12-bromo-2,16-dioxa-9,9,18,18-tetramethylpentacyclo[7.7.5.01,21.03,8.010,15]henicosa3(8),10,12,14-tetraene-7,20-dione compound, its synthesis, and its use as an antimicrobial agent.
Type:
Grant
Filed:
October 31, 2023
Date of Patent:
April 9, 2024
Assignee:
KING FAISAL UNIVERSITY
Inventors:
Hany Mohamed Abd El-Lateef Ahmed, Mai Mostafa Khalaf Ali, Antar Ahmed Abdelhamid Ahmed
Abstract: The present invention is directed to a medicinal composition, and more particularly, to a composition of chlorhexidine to treat lesions, particularly lesions caused by cold sores and herpes. The composition comprises chlorhexidine as the active ingredient. The composition also comprises a component for pain relief and a component for anti-inflammation. These three components, which act efficaciously in concert, are then combined with a suitable emollient or vehicle to form a topical formulation effective to treat the symptoms of cold sores and herpes. The composition may be formulated as an over-the-counter (OTC) topical formulation.
Abstract: This invention relates to dentifrice compositions comprising stannous fluoride and a silica abrasive having a N2 BET surface area of less than 50 m2/g and an Einlehner hardness of from 4 to 11, as well as to methods of using these compositions.
Type:
Grant
Filed:
April 19, 2021
Date of Patent:
March 19, 2024
Assignee:
Colgate-Palmolive Company
Inventors:
Madhuleena Bhadra, Michael Prencipe, Aarti Rege
Abstract: The present disclosure provides a composition for promoting hair growth including camellia kaempferol glycoside as an active ingredient. The composition for promoting hair growth according to an aspect of the present disclosure can promote hair growth by promoting the proliferation of hair follicle cells without side effects. In addition, the composition for promoting hair growth can promote hair growth and prevent hair loss by inhibiting the apoptosis of outer root sheath cells. Such a composition for promoting hair growth can be used as an external application to the skin, and can be used as a food, cosmetics or pharmaceutical composition.
Type:
Grant
Filed:
October 12, 2022
Date of Patent:
March 19, 2024
Assignee:
AMOREPACIFIC CORPORATION
Inventors:
Yonghee Lee, Jaeyoung Ko, Sungyeon Cho, Hyoung June Kim, Heungsoo Baek, Seunghyun Shin
Abstract: A natural hair oil treatment product and methods of producing the hair oil and using the oil. The hair oil includes multiple vegetable oils and natural products that are combined in a multi-step process, with the products providing therapy and/or treatment for the hair and scalp.
Abstract: The present disclosure provides topical compositions of rofecoxib and methods of making said compositions. The present disclosure also provides methods of using topical compositions of rofecoxib to treat inflammation.
Abstract: A product for providing a customized color shade sunscreen product to match a skin tone of a subject is provided. The product comprises a color dose formulation, an instruction and optionally a sunscreen. The color dose formulation has high concentration of pigments and is suitable for being mixed with a sunscreen to prepare a customized color shade sunscreen product. Also is a method of preparing a customized color shade sunscreen product to match a skin tone of a subject. Such method comprises mixing a selected color dose formulation with a sunscreen. The color dose formulations may be selected from six color shade compositions that offer color shades suitable for all skin tones. The customized color shade sunscreen product may provide a sensorial benefit such as dry touch, good spreadability, no white residues, oil control and UV protection and visible light.
Type:
Grant
Filed:
June 29, 2018
Date of Patent:
March 19, 2024
Assignee:
L'Oreal
Inventors:
Tassia Hanashiro, Angeles Fonolla-Moreno, Renata Souto Maior Afonso Ferreira
Abstract: The present invention relates to an extrudable photocrosslinkable hydrogel comprising a biochemically modified extracellular matrix (ECM) with an electroconductive nanomaterial embedded; a photoinitiator and a solvent, the method for its preparation starting from decellularized extracellular matrices (dECMs) and its applications for preparing electroconductive scaffolds, electroconductive extrudable hydrogels for in situ defect-filling, conductive grafts, in situ or in vitro printed tissues or organs, adhesives for different tissues, or bone adhesives.
Type:
Grant
Filed:
August 13, 2020
Date of Patent:
March 5, 2024
Assignee:
Universidad de los Andes
Inventors:
Carolina Muñoz Camargo, Juan Carlos Cruz Jiménez, Julián Andrés Serna Méndez, Laura Rueda Gensini, Javier Felipe Cifuentes Rueda, Daniela Natalia Céspedes Valenzuela
Abstract: Nanoparticles including tacrolimus, and a method for providing nanoparticles including tacrolimus as well as to nanoparticles including tacrolimus that are obtainable by said method. Also relates to the nanoparticles including tacrolimus for use as a medicament. Further relates to a mucoadhesive buccal film containing the nanoparticles including tacrolimus and the mucoadhesive buccal film for use as a medicament, especially in pediatric patients.
Abstract: The present disclosure relates to thienyloxazolones and analogues thereof of formula (III) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xanthomonas.
Type:
Grant
Filed:
July 3, 2019
Date of Patent:
January 30, 2024
Assignee:
Bayer Aktiengesellschaft
Inventors:
David Bernier, Stéphane Brunet, Jérémy Dufour, Thomas Knobloch, Lionel Nicolas, Tomoki Tsuchiya
Abstract: The specification generally relates to compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, where R, A1, A2 and A3 have any of the meanings defined herein. The specification also relates to the use of such compounds and salts thereof to treat or prevent DNA-PK mediated disease, including cancer. The specification further relates to pharmaceutical compositions comprising such compounds and salts; kits comprising such compounds and salts; methods of manufacture of such compounds and salts; intermediates useful in the manufacture of such compounds and salts; and to methods of treating DNA-PK mediated disease, including cancer, using such compounds and salts.
Type:
Grant
Filed:
June 14, 2019
Date of Patent:
January 30, 2024
Assignees:
AstraZeneca AB, Cancer Research Technology Limited
Inventors:
Maurice Raymond Verschoyle Finlay, Frederick Woolf Goldberg, Martin Richard Howard, Attilla Kuan Tsuei Ting
Abstract: The invention relates to a personal cleansing composition that delivers enhanced deposition of sunscreens on to the topical surface of the body. The composition more particularly provides for such wash off compositions that ensure that the sunscreens incorporated therein are stable and due to the high deposition on to surface provide high Sun Protection Factor (SPF). This is achieved through combination of two select water-soluble sunscreens in a high surfactant containing composition.
Abstract: A composition for treating acne includes an anti-acne active agent that includes salicylic acid, an emulsifier, an emollient, particles of zinc oxide, water and a humectant. The composition has a sun protection factor (SPF) of at least 5. The zinc oxide can be included in a powder with particles that are formed as aggregates of smaller particles which, when used in a dispersion at a concentration of 50 weight % of zinc oxide, produces a transparent composition.